Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE
Resource Type
Article
Authors
Mamounas, E.P. ; Untch, M. ; Mano, M.S. ; Huang, C.-S. ; Geyer Jr, C.E. ; von Minckwitz, G. ; Wolmark, N. ; Pivot, X. ; Kuemmel, S. ; DiGiovanna, M.P. ; Kaufman, B. ; Kunz, G. ; Conlin, A.K. ; Alcedo, J.C. ; Kuehn, T. ; Wapnir, I. ; Fontana, A. ; Hackmann, J. ; Polikoff, J. ; Saghatchian, M. ; Brufsky, A. ; Yang, Y. ; Zimovjanova, M. ; Boulet, T. ; Liu, H. ; Tesarowski, D. ; Lam, L.H. ; Song, C. ; Smitt, M. ; Loibl, S.
Source
In Annals of Oncology August 2021 32(8):1005-1014
Subject
Breast tumors
Language
ISSN
0923-7534